4 Healthcare Stock Stories Not To Be Overlooked

Pfizer (NYSE:PFE): Closing price $28.02

On Tuesday, the FDA strengthened its prior warning in regards to the potential risks of azithromycin, manufactured in part by Pfizer which is a commonly used antibiotic that can lead to changes in the electrical activity of the heart that cause a fatal irregular heart rhythm in some patients. The dangers have been noted in the warning labels on the drug since March of 2012, and were quantified in greater detail in a study published in the spring of 2012 in the New England Journal of Medicine, that was led by a professor of preventive medicine at Vanderbilt University in Nashville.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

PFE

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Premium Newsletters

Stock Investor Cheat Sheet

Stock Investor Cheat Sheet®

The ultimate Cheat Sheet for finding winning stock picks.
Learn More

Gold & Silver Newsletter

Gold & Silver

Don't miss one of the biggest bull markets in history! Covers Gold, Silver, Gold & Silver stocks, and miners.
Learn More

Commodities Premium Newsletter

Commodities Premium

There's always a bull market in some sector! Find the best opportunities in commodities.
Learn more

ETF Investing

ETF Investing

At last, a trading system that buys the right ETFs at the right time, time after time!
Learn more

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business